NASDAQ · Medical - Equipment & Services

Profusa, Inc. Common Stock (PFSA) Stock

$1.03 -39.77% NASDAQ: PFSA Healthcare

Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors.

Valuation

MetricValue
Price$1.03
Market Cap$22940
P/E Ratio-0.01
P/B Ratio-0.10
P/S Ratio0.00
EPS (TTM)$-107.01
52-Week High$2268.75
52-Week Low$0.87
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE154.23%
ROA-900.00%
ROCE107.44%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.44
Current Ratio0.18

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-12.0M$-11.0M$-6.0M$-4.0M$-13.0M
Net Profit$-10.0M$-20.0M$-10.0M$-9.0M$-36.0M
EPS$0.93$22.24$8.66$-357.13$-107.01
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$11.0M$1.0M$2.0M$3.0M$4.0M
Total Liabilities$95.0M$101.0M$112.0M$122.0M$30.0M
Cash$1.0M$0$0$0$2.0M
Borrowings$24.0M$31.0M$40.0M$48.0M$15.0M

Latest News

This Biotech Stock Crashed 28% Today After Announcing Second Reverse Share Split This Year Stocktwits · Jul 2, 2026 Profusa to Implement 1-for-25 Reverse Stock Split MT Newswires · Jul 2, 2026 Profusa Announces 1-for-25 Reverse Stock Split GlobeNewswire · Jul 2, 2026 BC-Most Active Stocks Associated Press · Jun 24, 2026 Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts GlobeNewswire · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-8.0M$-4.0M$-2.0M$-16.0M
Investing Cash Flow$0$0$0$0$-2.0M
Financing Cash Flow$0$-1.0M$-1.0M$-1.0M$10.0M
Net Cash Flow$-2.0M$-1.0M$0$0$2.0M
Free Cash Flow$-11.0M$-8.0M$-4.0M$-2.0M$-16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.30
FCF Yield-69747.17%
Quick Ratio0.18
Interest Coverage-2.60
Return 1Y-99.93%
Return 3Y—
Return 5Y—

Ownership

Insiders Held1.02%
Institutions Held0.58%
Institutions Float Held0.58%
Institutional HolderSharesReport Date
Citadel Advisors Llc1,2342026-03-31
Geode Capital Management, LLC1,2292026-03-31
Vanguard Capital Management LLC1582026-03-31
Tower Research Capital LLC (TRC)722026-03-31
Vanguard Fiduciary Trust Co682026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACXP $1.40 -1.40% -0.36 $2.22M 0.00%
ADIL $3.33 +1.22% -1.14 $3.20M 0.00%
APRE $0.62 -1.16% -0.47 $4.06M 0.00%
BCDABioCardia, Inc. $0.84 -1.11% -0.83 $4.88M 0.00%
BFRI $1.17 -4.88% -0.90 $14.98M 0.00%

About Profusa, Inc. Common Stock

Profusa, Inc. is a pioneering health technology firm that engineers advanced, bio-integrated sensors. These innovative devices, exemplified by their Lumee™ Oxygen Platform, are designed for uninterrupted observation of internal physiological markers. By leveraging artificial intelligence, Profusa translates this constant stream of data into actionable health insights, primarily to empower individuals and clinicians in the management of persistent health challenges like diabetes and critical limb ischemia.

Profusa, Inc. Common Stock is led by CEO Ben Chung-Bin Hwang, employs 2 people, headquartered in US, publicly traded since 2025.

Profusa, Inc. Common Stock (PFSA) stock trades at $1.03 with a market capitalization of $22940. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of -0.10, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.87 and $2268.75, and currently trades 100.0% below its 52-week high.

On profitability, Profusa, Inc. Common Stock generates a return on equity (ROE) of 154.23% — well above the market average, a sign of a high-quality business, return on capital employed of 107.44%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: profusa.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides